| Literature DB >> 32258817 |
Bogdan Sidonia1, Rafa Horatiu2, Luca Vlad1, Dulf Francisc3, Ober Ciprian1, Pestean Cosmin1, Oana Liviu1, Andrei Sanda2.
Abstract
INTRODUCTION: Oxidative stress (OS) seems to be an important mediator of cellular injury, from which sepsis can proceed. Studies have demonstrated the protective effect of controlled hypothermia in sepsis. This study aimed to evaluate its effects on OS parameters in rat hepatic and renal tissue septic after caecal ligation and puncture (CLP).Entities:
Keywords: hypothermia; oxidative stress; rats; sepsis
Year: 2020 PMID: 32258817 PMCID: PMC7105977 DOI: 10.2478/jvetres-2020-0004
Source DB: PubMed Journal: J Vet Res ISSN: 2450-7393 Impact factor: 1.744
Fig. 1Total proteins concentration in the liver and kidneys for each experimental condition (C – control; SN – sepsis normothermic; SH– sepsis hypothermic). * – different from control (P < 0.05); ** – different from SN (p < 0.05). Values are expressed as means ± SD
Fig. 2GPx and SOD activity in the liver (A) and kidneys (B) for each experimental condition (C – control; SN – sepsis normothermic; SH – sepsis hypothermic). * – different from control (p < 0.05); ** – different from SN (p < 0.05). Values are expressed as means ± SD
Fig. 3MDA and DNPH concentrations in the liver (A) and kidneys (B) for each experimental condition (C – control; SN – sepsis normothermic; SH – sepsis hypothermic). * – different from control; ** – different from SN (p < 0.05). Values are expressed as means ± SD
Fig. 4GC-MS chromatogram of the FAMEs from total lipids of the liver (SH – sepsis hypothermic group) analysed with a BPx-70 column. Peaks of fatty acids: (1) palmitic (16:0); (2) palmitoleic (16:1 n–7); (3) stearic (18:0); (4) oleic (18:1 n–9); (5) linoleic (18:2 n–9); and (6) arachidonic (20:4 n–6)
Fig. 5GC-MS chromatogram of the FAMEs from total lipids of kidneys (SN – sepsis normothermic group) analysed with a BPx-70 column. Peaks of fatty acids: (1) myristic (14:0); (2) palmitic (16:0); (3) palmitoleic (16:1 n–7); (4) stearic (18:0); (5) oleic (18:1 n–9); (6) linoleic (18:2 n–6); and (7) arachidonic (20:4 n–6)
Fatty acid composition of total lipids determined by GC-MS in the liver and kidneys for each experimental condition (C – control; SN – sepsis normothermic; SH – sepsis hypothermic)
| Fatty acid % a | ||||||
|---|---|---|---|---|---|---|
| Fatty acid | C | Liver SN | SH | C | Kidneys SN | SH |
| Myristic (14:0) | nd | nd | nd | 0.17 ± 0.09 | 1.01 ± 0.01 | 0.15 ± 0.01 |
| Palmitic (16:0) | 26.61 ± 1.21 | 24.48 ± 1.03 | 23.17 ± 0.98 | 7.17 ± 0.21 | 24.53 ± 1.06 | 9.71 ± 0.42 |
| Palmitoleic (16:1 n–9) | 0.16 ± 0.08 | 0.19 ± 0.06 | 0.17 ± 0.11 | 0.8 ± 0.09 | 0.21 ± 0.05 | 0.78 ± 1.01 |
| Palmitoleic (16:1 n–7) | 0.96 ± 0.12 | 0.92 ± 0.19 | 0.98 ± 0.11 | 0.26 ± 0.07 | 3.92 ± 0.24 | nd |
| Stearic (18:0) | 18.02 ± 1.13 | 29.69 ± 1.65 | 26.65 ± 1.16 | 0.53 ± 0.03 | 6.88 ± 0.29 | 0.62 ± 0.13 |
| Oleic (18:1 n–9) | 8.48 ± 0.32 | 5.15 ± 0.19 | 8.43 ± 0.28 | 69.22 ± 1.69 | 50.16 ± 1.53 | 67.62 ± 0.63 |
| Oleic (18:1 n–7) | 2.71 ± 0.13 | 1.94 ± 0.16 | 1.4 ± 0.09 | 4.01 ± 0.24 | 3.3 ± 0.52 | 3.59 ± 0.12 |
| Linoleic (18:2 n–9) | 14.12 ± 0.5 | 13.49 ± 0.29 | 12.88 ± 0.33 | 13.01 ± 0.31 | 9.85 ± 0.22 | 13.4 ± 0.52 |
| Arachidonic (20:4 n–6) | 28.94 ± 0.89 | 24.15 ± 0.91 | 26.32 ± 1.41 | 4.83 ± 0.12 | 0.14 ± 0.06 | 4.12 ± 0.16 |
– % of total fatty acids; nd – not detected. Values are mean ± standard deviation of samples analysed individually in triplicate
Statistical analysis of fatty acid distribution in total lipids for each experimental condition (C – control; SN – sepsis normothermic; SH – sepsis hypothermic)
| Fatty acid/% a | ||||||
|---|---|---|---|---|---|---|
| Type of tissues/ | group | Σ SFAs | Σ MUFAs | Σ PUFAs | Σ UFAs | Σ UFAs / Σ SFAs |
| C | 44.63 ± 1.79 | 12.31 ± 0.46 | 43.06 ± 1.46 | 55.37 ± 2.13 | 1.24 | |
| Liver | SN | 54.17 ± 1.65* | 8.19 ± 0.29* | 37.63 ± 1.38* | 50.19 ± 1.98* | 0.84* |
| SH | 49.82 ± 1.84*,** | 10.98 ± 0.36*,** | 39.19 ± 1.65 | 45.83 ± 1.73*,** | 1.007** | |
| C | 7.87 ± 0.53 | 74.29 ± 2.93 | 17.84 ± 0.55 | 92.13 ± 3.69 | 11.70 | |
| Kidneys | SN | 32.42 ± 1.27* | 57.59 ± 1.95* | 9.99 ± 0.37* | 67.58 ± 2.24* | 2.08* |
| SH | 10.48 ± 0.67*,** | 72.00 ± 2.63** | 17.52 ± 0.51 | 89.52 ± 3.33** | 8.54** | |
– % of total fatty acids; * – different from control; ** – different from SN (P < 0.05); SFAs – saturated fatty acids; MUFAs – monounsaturated fatty acid; PUFAs – polyunsaturated fatty acids; UFAs – unsaturated fatty acids. Values are mean ± standard deviation of samples analysed individually in triplicate